Loss of Alx4, a stromally-restricted homeodomain protein, impairs mammary epithelial morphogenesis

Developmental Biology

Volumn 297, Issue 1, 2006, Pages 284-294

  Joshi, Purna A ^a   Chang, Hong ^a   Hamel, Paul A ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Alx4; Estrogen receptor; Mammary gland; Stroma; Strong's luxoid; Terminal end bud

Indexed keywords

ESTRADIOL; ESTROGEN RECEPTOR ALPHA; GELATINASE B; HOMEODOMAIN PROTEIN; SCATTER FACTOR; STROMELYSIN; TRANSCRIPTION FACTOR ALX4; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BREAST DEVELOPMENT; BREAST DUCT; BREAST EPITHELIUM; CONTROLLED STUDY; EXPERIMENTAL MOUSE; FEMALE; FREQUENCY ANALYSIS; HOMOZYGOSITY; HORMONAL REGULATION; MAMMARY GLAND; MORPHOGENESIS; MOUSE; MUTANT; NONHUMAN; POPULATION RESEARCH; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PUBERTY; STATISTICAL SIGNIFICANCE; STROMA CELL; WILD TYPE;

ANIMALIA;

EID: 33748154179     PISSN: 00121606     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ydbio.2006.05.032     Document Type: Article

References (41)

1. Boras K., and Hamel P.A. Alx4 binding to LEF-1 regulates N-CAM promoter activity. J. Biol. Chem. 277 (2002) 1120-1127
2. Boras-Granic K., Grosschedl R., and Hamel P.A. Genetic interaction between Lef1 and Alx4 is required for early embryonic development. Int. J. Dev. Biol. 50 7 (2006) 601-610
3. Chan D.C., Laufer E., Tabin C., and Leder P. Polydactylous limbs in Strong's Luxoid mice result from ectopic polarizing activity. Development 121 (1995) 1971-1978
4. Fendrick J.L., Raafat A.M., and Haslam S.Z. Mammary gland growth and development from the postnatal period to postmenopause: ovarian steroid receptor ontogeny and regulation in the mouse. J. Mammary Gland Biol. Neoplasia 3 (1998) 7-22
5. Forsthoefel P.F. Genetics and manifold effects of Strong's luxoid gene in the mouse, including its interactions with Green's luxoid and Carter's luxate genes. J. Morphol. 110 (1962) 391-420
6. Forsthoefel P.F. The embryological development of the effects of strong's luxoid gene in the mouse. J. Morphol. 113 (1963) 427-451
7. Forsthoefel P.F., Fritts M.L., and Hatzenbeler L.J. The origin and development of alopecia in mice homozygous for strong's luxoid gene. J. Morphol. 118 (1966) 565-580
8. Gouon-Evans V., Rothenberg M.E., and Pollard J.W. Postnatal mammary gland development requires macrophages and eosinophils. Development 127 (2000) 2269-2282
9. Gouon-Evans V., Lin E.Y., and Pollard J.W. Requirement of macrophages and eosinophils and their cytokines/chemokines for mammary gland development. Breast Cancer Res. 4 (2002) 155-164
10. Hudson R., Taniguchi-Sidle A., Boras K., Wiggan O., and Hamel P.A. Alx-4, a transcriptional activator whose expression is restricted to sites of epithelial-mesenchymal interactions. Dev. Dyn. 213 (1998) 159-169
11. Ip M.M., and Darcy K.M. Three-dimensional mammary primary culture model systems. J. Mammary Gland Biol. Neoplasia 1 (1996) 91-110
12. Kamalati T., Niranjan B., Yant J., and Buluwela L. HGF/SF in mammary epithelial growth and morphogenesis: in vitro and in vivo models. J. Mammary Gland Biol. Neoplasia 4 (1999) 69-77
13. Kleinberg D.L., Feldman M., and Ruan W. IGF-I: an essential factor in terminal end bud formation and ductal morphogenesis. J. Mammary Gland Biol. Neoplasia 5 (2000) 7-17
14. Kratochwil K., Dull M., Farinas I., Galceran J., and Grosschedl R. Lef1 expression is activated by BMP-4 and regulates inductive tissue interactions in tooth and hair development. Genes Dev. 10 (1996) 1382-1394
15. Mallepell S., Krust A., Chambon P., and Brisken C. Paracrine signaling through the epithelial estrogen receptor alpha is required for proliferation and morphogenesis in the mammary gland. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 2196-2201
16. Master S.R., Stoddard A.J., Bailey L.C., Pan T.C., Dugan K.D., and Chodosh L.A. Genomic analysis of early murine mammary gland development using novel probe-level algorithms. Genome Biol. 8 (2005) R20
17. Mavrogiannis L.A., Antonopoulou I., Baxova A., Kutilek S., Kim C.A., Sugayama S.M., Salamanca A., Wall S.A., Morriss-Kay G.M., and Wilkie A.O. Haploinsufficiency of the human homeobox gene ALX4 causes skull ossification defects. Nat. Genet. 27 (2001) 17-18
18. Nandi S. Endocrine control of mammarygland development and function in the C3H/He Crgl mouse. J. Natl. Cancer Inst. 21 (1958) 1039-1063
19. Niranjan B., Buluwela L., Yant J., Perusinghe N., Atherton A., Phippard D., Dale T., Gusterson B., and Kamalati T. HGF/SF: a potent cytokine for mammary growth, morphogenesis and development. Development 121 (1995) 2897-2908
20. Pollard J.W., and Hennighausen L. Colony stimulating factor 1 is required for mammary gland development during pregnancy. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 9312-9316
21. Qu S., Li L., and Wisdom R. Alx-4: cDNA cloning and characterization of a novel paired-type homeodomain protein. Gene 203 (1997) 217-223
22. Qu S., Tucker S.C., Ehrlich J.S., Levorse J.M., Flaherty L.A., Wisdom R., and Vogt T.F. Mutations in mouse Aristaless-like4 cause Strong's luxoid polydactyly. Development 125 (1998) 2711-2721
23. Rasmussen S.B., Young L.J.T., and Smith G.H. Preparing Mammary Gland Whole Mounts from Mice (2000), Plenum Publishers, New York
24. Richert M.M., Schwertfeger K.L., Ryder J.W., and Anderson S.M. An atlas of mouse mammary gland development. J. Mammary Gland Biol. Neoplasia 5 (2000) 227-241
25. Robinson G.W., Karpf A.B., and Kratochwil K. Regulation of mammary gland development by tissue interaction. J. Mammary Gland Biol. Neoplasia 4 (1999) 9-19
26. Ruan W., and Kleinberg D.L. Insulin-like growth factor I is essential for terminal end bud formation and ductal morphogenesis during mammary development. Endocrinology 140 (1999) 5075-5081
27. Silberstein G.B. Postnatal mammary gland morphogenesis. Microsc. Res. Tech. 52 (2001) 155-162
28. Silberstein G.B., Van Horn K., Shyamala G., and Daniel C.W. Essential role of endogenous estrogen in directly stimulating mammary growth demonstrated by implants containing pure antiestrogens. Endocrinology 134 (1994) 84-90
29. Soriano J.V., Pepper M.S., Orci L., and Montesano R. Roles of hepatocyte growth factor/scatter factor and transforming growth factor-beta1 in mammary gland ductal morphogenesis. J. Mammary Gland Biol. Neoplasia 3 (1998) 133-150
30. Sternlicht M.D., Sunnarborg S.W., Kouros-Mehr H., Yu Y., Lee D.C., and Werb Z. Mammary ductal morphogenesis requires paracrine activation of stromal EGFR via ADAM17-dependent shedding of epithelial amphiregulin. Development 132 (2005) 3923-3933
31. Valente M., Valente K.D., Sugayama S.S., and Kim C.A. Malformation of cortical and vascular development in one family with parietal foramina determined by an ALX4 homeobox gene mutation. AJNR Am. J. Neuroradiol. 25 (2004) 1836-1839
32. van Genderen C., Okamura R.M., Farinas I., Quo R.G., Parslow T.G., Bruhn L., and Grosschedl R. Development of several organs that require inductive epithelial-mesenchymal interactions is impaired in LEF-1-deficient mice. Genes Dev. 8 (1994) 2691-2703
33. Veltmaat J.M., Mailleux A.A., Thiery J.P., and Bellusci S. Mouse embryonic mammogenesis as a model for the molecular regulation of pattern formation. Differentiation 71 (2003) 1-17
34. Walden P.D., Ruan W., Feldman M., and Kleinberg D.L. Evidence that the mammary fat pad mediates the action of growth hormone in mammary gland development. Endocrinology 139 (1998) 659-662
35. Wiseman B.S., and Werb Z. Stromal effects on mammary gland development and breast cancer. Science 296 (2002) 1046-1049
36. Wiseman B.S., Sternlicht M.D., Lund L.R., Alexander C.M., Mott J., Bissell M.J., Soloway P., Itohara S., and Werb Z. Site-specific inductive and inhibitory activities of MMP-2 and MMP-3 orchestrate mammary gland branching morphogenesis. J. Cell Biol. 162 (2003) 1123-1133
37. Woodward T.L., Xie J.W., and Haslam S.Z. The role of mammary stroma in modulating the proliferative response to ovarian hormones in the normal mammary gland. J. Mammary Gland Biol. Neoplasia 3 (1998) 117-131
38. Wu Y.Q., Badano J.L., McCaskill C., Vogel H., Potocki L., and Shaffer L.G. Haploinsufficiency of ALX4 as a potential cause of parietal foramina in the 11p11.2 contiguous gene-deletion syndrome. Am. J. Hum. Genet. 67 (2000) 1327-1332
39. Wuyts W., Cleiren E., Homfray T., Rasore-Quartino A., Vanhoenacker F., and Van Hul W. The ALX4 homeobox gene is mutated in patients with ossification defects of the skull (foramina parietalia permagna, OMIM 168500). J. Med. Genet. 37 (2000) 916-920
40. Yang Y., Spitzer E., Meyer D., Sachs M., Niemann C., Hartmann G., Weidner K.M., Birchmeier C., and Birchmeier W. Sequential requirement of hepatocyte growth factor and neuregulin in the morphogenesis and differentiation of the mammary gland. J. Cell Biol. 131 (1995) 215-226
41. Zhang H.Z., Bennett J.M., Smith K.T., Sunil N., and Haslam S.Z. Estrogen mediates mammary epithelial cell proliferation in serum-free culture indirectly via mammary stroma-derived hepatocyte growth factor. Endocrinology 143 (2002) 3427-3434